Low level of hepatitis b virus screening among patients receiving chemotherapy

Clinical Gastroenterology and Hepatology

Volumn 13, Issue 5, 2015, Pages 970-975

  Wi, Chung Il ^a   Loo, Nicole M ^c   Larson, Joseph J ^b   Moynihan, Timothy J ^b   Madde, Nageswar R ^b   Grendahl, Darryl C ^b   Alberts, Steven R ^b   Kim, W Ray ^a,d  

^a MAYO CLINIC   (United States)

^b Mayo Clinic College of Medicine   (United States)

^c YALE UNIVERSITY   (United States)

^d STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Abnormal liver enzyme; Preemptive antiviral; Risk factor; Universal screening

Indexed keywords

ALANINE AMINOTRANSFERASE; HEPATITIS B SURFACE ANTIGEN; ANTINEOPLASTIC AGENT;

ADULT; AGED; ANTIVIRAL THERAPY; ARTICLE; CANCER CHEMOTHERAPY; CONTROLLED STUDY; FEMALE; HEMATOLOGIC MALIGNANCY; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; RETROSPECTIVE STUDY; SCREENING TEST; SOLID TUMOR; VIRUS REACTIVATION; CHEMICALLY INDUCED; COHORT ANALYSIS; COMPLICATION; DRUG EFFECTS; DRUG THERAPY; HEALTH SERVICES RESEARCH; MASS SCREENING; MIDDLE AGED; MINNESOTA; NEOPLASMS; PHYSIOLOGY; PROCEDURES; VERY ELDERLY; VIRUS ACTIVATION;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS; COHORT STUDIES; DRUG THERAPY; FEMALE; HEALTH SERVICES RESEARCH; HEPATITIS B; HEPATITIS B VIRUS; HUMANS; MALE; MASS SCREENING; MIDDLE AGED; MINNESOTA; NEOPLASMS; RETROSPECTIVE STUDIES; VIRUS ACTIVATION;

EID: 84927910917     PISSN: 15423565     EISSN: 15427714     Source Type: Journal    
DOI: 10.1016/j.cgh.2014.10.032     Document Type: Article

References (15)

1. Lau G.K., Yiu H.H., Fong D.Y., et al. Early is superior to deferred preemptive lamivudine therapy for hepatitis B patients undergoing chemotherapy. Gastroenterology 2003, 125:1742-1749.
2. Hsu C., Hsiung C.A., Su I.J., et al. Arevisit of prophylactic lamivudine for chemotherapy-associated hepatitis B reactivation in non-Hodgkin's lymphoma: a randomized trial. Hepatology 2008, 47:844-853.
3. Weinbaum C.M., Williams I., Mast E.E., et al. Recommendations for identification and public health management of persons with chronic hepatitis B virus infection. MMWR Morb Mortal Wkly Rep 2008, 57:1-20.
4. Lok A.S., McMahon B.J. Chronic hepatitis B: update 2009. Hepatology 2009, 50:661-662.
5. Artz A.S., Somerfield M.R., Feld J.J., et al. American Society of Clinical Oncology provisional clinical opinion: chronic hepatitis B virus infection screening in patients receiving cytotoxic chemotherapy for treatment of malignant diseases. JClin Oncol 2010, 28:3199-3202.
6. Day F.L., Karnon J., Rischin D. Cost-effectiveness of universal hepatitis B virus screening in patients beginning chemotherapy for solid tumors. JClin Oncol 2011, 29:3270-3277.
7. Zurawska U., Hicks L.K., Woo G., et al. Hepatitis B virus screening before chemotherapy for lymphoma: a cost-effectiveness analysis. JClin Oncol 2012, 30:3167-3173.
8. Hwang JP, Bardo A, Perrillo R. International survey on reactivation of hepatitis B induced by cancer chemotherapy (abstr). AASLD Emerg Trends Conf 2013;2013.
9. Hwang J.P., Fisch M.J., Zhang H., et al. Low rates of hepatitis B virus screening at the onset of chemotherapy. JOncol Pract 2012, 8:e32-e39.
10. Artz AS, Somerfield MR, Feld JJ, etal. Special announcement, 2013. ASCO Provisional Clinical Opinion: chronic hepatitis B virus infection screening in patients receiving cytotoxic chemotherapy for treatment of malignant diseases. Available: J Clin Oncol 2010;28:3199-3202. http://www.asco.org/quality-guidelines/asco-provisional-clinical-opinion-chronic-hepatitis-b-virus-infection-screening.
11. Tran T.T., Rakoski M.O., Martin P., et al. Screening for hepatitis B in chemotherapy patients: survey of current oncology practices. Aliment Pharmacol Ther 2010, 31:240-246.
12. Khokhar O.S., Farhadi A., McGrail L., et al. Oncologists and hepatitis B: a survey to determine current level of awareness and practice of antiviral prophylaxis to prevent reactivation. Chemotherapy 2009, 55:69-75.
13. Day F.L., Link E., Thursky K., et al. Current hepatitis B screening practices and clinical experience of reactivation in patients undergoing chemotherapy for solid tumors: a nationwide survey of medical oncologists. JOncol Pract 2011, 7:141-147.
14. Yeo W., Chan H.L. Hepatitis B virus reactivation associated with anti-neoplastic therapy. JGastroenterol Hepatol 2013, 28:31-37.
15. Jang J.W., Choi J.Y., Bae S.H., et al. Arandomized controlled study of preemptive lamivudine in patients receiving transarterial chemo-lipiodolization. Hepatology 2006, 43:233-240.